Preview

Medical alphabet

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

The effect of arterial hypertension and coronary heart disease on the course and outcome of COVID‑19

https://doi.org/10.33667/2078-5631-2025-3-7-11

Abstract

Objective. To investigate the influence of arterial hypertension (AH) and ischemic heart disease (IHD) on the course and outcomes of COVID19, considering their various stages, forms, and target organ involvement.
Materials and мethods. A total of 808 COVID19 patients hospitalized in the Intensive Care Unit (ICU) from October 1 to December 31, 2020, aged between 17 and 97 years, were examined. The first group consisted of 246 patients without comorbidities. The second group included 430 patients with AH: 305 with stage II and 125 with stage III. The third group comprised 132 patients with IHD and AH: 84 with angina pectoris, 24 with postinfarction cardiosclerosis, and 24 with acute myocardial infarction (AMI). Clinical and laboratory parameters were assessed for all patients, along with electrocardiography, echocardiography, Doppler ultrasound of the lower extremity veins, and computed tomography (CT) of the thoracic organs. In 110 deceased patients, the severity of lung involvement, signs of heart failure, and the immediate cause of death were evaluated.
Results. Among COVID19 patients hospitalized in the ICU, the prevalence of AH was 70%, including 16.5% with IHD, and 22% had concomitant diabetes mellitus. The mortality rate among COVID19 patients without cardiovascular diseases (CVD) was 4.5%. Among those with Stage II AH, including those with IHD and angina, the mortality rates were 8.2% and 14.3%, respectively. In patients with stage III AH with renal or cardiac involvement, mortality rates were 24% and 62.5%, respectively.
Conclusion. Risk stratification for mortality, considering the prognostically unfavorable significance of the stages and forms of AH and IHD, as well as concomitant viral infections with respiratory complications, allows for an objective assessment of disease progression and prognosis.

About the Authors

M. U. Keshtova
N.V. Sklifosovsky Research Institute for Emergency Medicine, Moscow, Russia
Russian Federation

Keshtova Marianna U., cardiologist, junior researcher



G. A. Ghazaryan
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation

Ghazaryan Georgy A., DM Sci (habil.), professor



S. S. Petrikov
N.V. Sklifosovsky Research Institute for Emergency Medicine
Russian Federation

Petrikov Sergey S., DM Sci (habil.), corresponding  member of the Russian Academy of Sciences, director



References

1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. https://doi.org/10.1001/jama.2020.2648

2. Fried J.A., Ramasubbu K., Bhatt R., Topkara V.K., Clerkin K.J., Horn E, Rabbani L., Brodie D., Jain S.S., Kirtane A.J. The variety of cardiovascular presentations of COVID19. Circulation. 2020;141(23):1930–1936. https://doi.org/10.1161/CIRCULATIONAHA.120.047164

3. Henein M.Y., Cameli M., Pastore М.С., Mandoli G.E. COVID19 Severity and cardiovascular disease: an inseparable link.. J Clin Med. 2022;11(3):479. https://doi.org/10.3390/jcm11030479

4. Azevedo R. B., Botelho B. G., Goncalves de Hollanda J. V., Ferreira L. V.L., de Andrade L.Z.J., Lilienwald Oei S.S.M., de Souza Mello T., Muxfeldt E.S. Covid19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021;35(1):4–11. https://doi.org/10.1038/s4137102003874

5. Салухов В. В., Арутюнов Г.П., Тарловская Е. И., Батлук Т. И., Башкинов Р. А., Самусь И.В., Мельников Е.С., Трубникова М.А., Арутюнов А. Г. Влияние нарушений углеводного обмена на ранние и отдаленные клинические исходы у пациентов с COVID19 по данным регистров АКТИВ и АКТИВ 2. Проблемы Эндокринологии. 2023;69(1):36–49. (In Russ.). https://doi.org/10.14341/probl13175 Salukhov V.V., Arutyunov G.P., Tarlovskaya E.I., Batluk T.I., Bashkinov R.A., Samus I.V., Melnikov E.S., Trubnikova M.A., Arutyunov A.G. The impact of carbohydrate metabolism disorders on early and late clinical outcomes in patients with COVID19 according to the ACTIVE and ACTIVE2 registries. Problems of Endocrinology. 2023;69(1):36–49. https://doi.org/10.14341/probl13175

6. Gao Y.D., Ding M., Dong X., Zhang J.J., Kursat Azkur A., Azkur D., Gan H., Sun Y.L., Fu W., Li W., Liang H.L., Cao Y.Y., Yan Q., Cao C., Gao H.Y., Brüggen M.C., van de Veen W., Sokolowska M., Akdis M., Akdis C.A. Risk factors for severe and critically ill COVID19 patients: A review. Allergy. 2021;76(2):428–455. https://doi.org/10.1111/all.14657

7. Шляхто Е.В., Конради А.О., Арутюнов Г.П., Арутюнов А.Г., Баутин А.Е., Бойцов С.А., Виллевальде С.В., Григорьева Н.Ю., Дупляков Д.В., Звартау Н.Э., Козиолова Н.А., Лебедев Д.С., Мальчикова С.В., Медведева Е.А., Михайлов Е.Н., Моисеева О.М., Орлова Я.А., Павлова Т. В., Певзнер Д. В., Петрова М.М., Ребров А.П., Ситникова М.Ю., Соловьева А.Е., Тарловская Е.И., Трукшина М.А., Федотов П.А., Фомин И.В., Хрипун А.В., Чесникова А.И., Шапошник И.И., Явелов И.С., Яковлев А.Н. Руководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID19. Российский кардиологический журнал. 2020; 25 (3): 3801. (In Russ.). https://doi.org/10.15829/15604071202033801 Shlyakhto E.V., Konradi A.O., Arutyunov G.P., Arutyunov A.G., Bautin A.E., Boytsov S.A., Villevalde S.V., Grigorieva N. Yu., Duplyakov D.V., Zvartau N.E., Koziolova N.A., Lebedev D.S., Malchikova S.V., Medvedeva E.A., Mikhailov E.N., Moiseeva O.M., Orlova Y.A., Pavlova T.V., Pevzner D.V., Petrova M.M., Rebrov A.P., Sitnikova M. Yu., Solovyova A.E., Tarlovskaya E.I., Trukshina M.A., Fedotov P.A., Fomin I.V., Khripun A.V., Chesnikova A.I., Shaposhnik I.I., Yavelov I.S., Yakovlev A.N. Guidelines for the diagnosis and treatment of diseases of the circulatory system in the context of the COVID19 pandemic. Russian Journal of Cardiology. 2020;25(3):3801. https://doi.org/10.15829/15604071202033801

8. Кештова М.У., Газарян Г.А., Попугаев К.А., Петриков С.С. Влияние артериальной гипертонии и ишемической болезни сердца на течение и исход COVID19. Современные технологии оказания экстренной и неотложной медицинской помощи на госпитальном этапе: материалы 6-го съезда врачей неотложной медицины, приуроченного к 100-летию НИИ СП им. Н. В. Склифосовского ДЗМ (Москва, 19–20 октября 2023 года). Москва: НПО ВНМ, НИИ СП им. Н.В. Склифосовского ДЗМ; 2023: 178–179. (In Russ.). Keshtova M.U., Gazaryan G.A., Popugaev K.A., Petrikov S.S. The impact of arterial hypertension and coronary heart disease on the course and outcome of COVID19. Modern technologies for providing emergency and urgent medical care at the hospital stage: Proceedings of the 6th Congress of Emergency Medicine Physicians, dedicated to the 100th anniversary of the N.V. Sklifosovsky Research Institute of Emergency Medicine, Department of Health of Moscow (Moscow, October 19–20, 2023). Moscow: NPO VNM, N.V. Sklifosovsky Research Institute of Emergency Medicine, Department of Health of the City of Moscow; 2023:178–179.

9. Сычева А. С., Малявина М. А., Тебуева Л. В., Григорьевский Е. Д., Кебина А. Л., Верткин А.Л., Солодов А.А., Семенякин И.В., Левченко О.В., Янушевич О.О. Особенности течения коронавирусной инфекции COVID19 у пациентов с коморбидной патологией. Терапия. 2022; 6: 11–26. (In Russ.). https://doi.org/10.18565/therapy.2022.6.11–26 Sycheva A.S., Malyavina M.A., Tebueva L.V., Grigorievsky E.D., Kebina A.L., Vertkin A.L., Solodov A.A., Semenyakin I.V., Levchenko O.V., Yanushevich O.O. Features of the course of coronavirus infection COVID19 in patients with comorbid pathology. Therapy. 2022;6:11–26. https://doi.org/10.18565/therapy.2022.6.11–26

10. Gibson P.G., Qin L., Puah S.H. COVID19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID19 ARDS. Med J Aust. 2020;213(2):54–56. https://doi.org/10.5694/mja2.50674

11. Заболотских И.Б., Киров М.Ю., Лебединский К.М., Проценко Д.Н., Авдеев С.Н., Андреенко А.А., Арсентьев Л.В., Афончиков В.С., Афуков И.И., Белкин А.А., Боева Е.А., Буланов А.Ю. Анестезиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID19. Методические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов». Вестник интенсивной терапии имени А.И. Салтанова. 2022; 1: 5–140. (In Russ.). https://doi.org/10.21320/1818–474X202215140 Zabolotskikh I.B., Kirov M. Yu., Lebedinsky K.M., Protsenko D.N., Avdeev S.N., Andreenko A.A., Arsenyev L.V., Afonchikov V.S., Afukov I.I., Belkin A.A., Boeva E.A., Bulanov A. Yu. Anesthesiology and resuscitation care of patients with the new coronavirus infection COVID19. Guidelines of the All-Russian public organization «Federation of Anesthesiologists and Resuscitators». Bulletin of Intensive Therapy named after A.I. Saltanov. 2022; 1: 5–140. https://doi.org/10.21320/1818–474X202215140

12. Hu B., Huang S., Yin L. The cytokine storm and COVID19. J Med Virol. 2021;93(1):250–256. https://doi.org/10.1002/jmv.26232

13. Aslan A., Aslan C., Zolbanin N. M., Jafari R. Acute respiratory distress syndrome in COVID19: possible mechanisms and therapeutic management. Pneumonia (Nathan). 2021;13(1):14. https://doi.org/10.1186/s41479021000929

14. Manrique S., Claverias L., Magret M., Masclans J.R., Bodi M., Trefler S., Canadell L., Díaz E., Sole-Violan J., Bisbal-Andrés E., Natera R.G., Moreno A.A., Vallverdu M., Ballesteros J.C., Socias L., Vidal F.G., Sancho S., Martin-Loeches I., Rodriguez A. Timing of intubation and ICU mortality in COVID19 patients: a retrospective analysis of 4198 critically ill patients during the first and second waves. BMC Anesthesiol. 2023;23(1):140. https://doi.org/10.1186/s12871023020815

15. Yamamoto R., Kaito D., Homma K., Endo A., Tagami T., Suzuki M., Umetani N., Yagi M., Nashiki E., Suhara T., Nagata H., Kabata H., Fukunaga K., Yamakawa K., Hayakawa M., Ogura T., Hirayama A., Yasunaga H., Sasaki J. Early intubation and decreased in-hospital mortality in patients with coronavirus disease 2019. Crit Care. 2022;26(1):124. https://doi.org/10.1186/s13054022039951

16. Kummer R. L., Marini J.J. The Respiratory Mechanics of COVID19 Acute Respiratory Distress Syndrome – Lessons Learned? J Clin Med. 2024;13:1833. https://doi.org/10.3390/jcm13071833


Review

For citations:


Keshtova M.U., Ghazaryan G.A., Petrikov S.S. The effect of arterial hypertension and coronary heart disease on the course and outcome of COVID‑19. Medical alphabet. 2025;(3):7-11. (In Russ.) https://doi.org/10.33667/2078-5631-2025-3-7-11

Views: 77


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)